What peptide products does Thinheal supply?

Thinheal supplies generic peptide APIs, therapeutic peptides including GLP-1 and GLP-2 analogues, other gastrointestinal peptides, other therapeutic peptide APIs and cosmetic peptides, plus custom peptide R&D and CDMO manufacturing.

Does Thinheal offer custom peptide synthesis and CDMO services?

Yes. The CDMO business covers project-based contract research and development, contract manufacturing and commercial supply, from route design and process optimization to scale-up of peptide APIs and support toward formulations.

What production capacity does Thinheal have?

Thinheal operates an R&D center and a production base. Total capacity for chemically synthesized peptides has reached a multi-ton level, placing the company among the leading peptide producers in its segment.

Which quality documents can buyers request?

Buyers can request batch-specific Certificates of Analysis with HPLC purity and mass spectrometry identity data, and discuss additional documentation such as specifications, stability information and regulatory support files with the sales team for each project.

How can international buyers get the latest product catalog?

Use the Request a Catalog page or contact the regional desk for the USA and Europe, Russia and CIS, Asia, or the Middle East and East Asia by email, phone or WhatsApp.

Custom Retatrutide CAS 2381089-83-2: Innovative Obesity & T2DM Treatment from China Suppliers & Factory Manufacturers, Service

1 / 2

Custom Retatrutide CAS 2381089-83-2: Innovative Obesity & T2DM Treatment from China Suppliers & Factory Manufacturers, Service

Obesity and type 2 diabetes mellitus (T2DM) have become pressing global health issues, leading to substantial morbidity and mortality rates. Retatrutide is an innovative triple receptor agonist that effectively targets glucagon-like peptide-1 (GLP-1), Glucose-Dependent Insulinotropic Polypeptide (GIP), and glucagon receptors. This groundbreaking treatment offers a promising solution for managing obesity and T2DM, making it a crucial addition to the pharmacotherapy landscape. As a leading product, Retatrutide is available from reputable suppliers and manufacturers in China, ensuring high-quality and effective solutions for those struggling with these chronic conditions

Send Inquiry

Product Description

Obesity and type 2 diabetes mellitus (T2DM) are global health crises with significant morbidity and mortality. Retatrutide, a novel triple receptor agonist targeting glucagon-like peptide-1 (GLP-1), Glucose-Dependent Insulinotropic Polypeptide (GIP), and glucagon receptors, represents a groundbreaking advancement in obesity and T2DM pharmacotherapy.

Mechanism & Efficacy

Retatrutide is a novel multi-agonist peptide targeting GLP-1, GIP, and glucagon receptors, designed to enhance glucose regulation, promote weight loss, and support metabolic health. It is under active investigation in clinical and preclinical research for obesity and type 2 diabetes management.

Dosage & Research Use

Retatrutide is currently an investigational peptide in Phase 3 clinical trials and not yet FDA‑approved for clinical use. Trial protocols have explored once‑weekly subcutaneous doses ranging from 1 mg up to 12 mg, often titrated over multiple 4‑week intervals to balance efficacy and tolerability.

Frequently Asked Questions

What is Retatrutide?

Retatrutide is an experimental triple receptor agonist that targets GLP-1, GIP, and glucagon receptors to treat obesity and type 2 diabetes.

How does Retatrutide differ from existing treatments?

Unlike single or dual agonists, Retatrutide targets three different metabolic pathways (GLP-1, GIP, and glucagon) to potentially offer superior glucose regulation and weight loss.

Is Retatrutide currently available for medical use?

No, it is currently an investigational drug in Phase 3 clinical trials and has not yet received FDA approval for clinical or public use.

What dosages are being studied in clinical trials?

Research protocols typically involve once-weekly subcutaneous injections ranging from 1 mg to 12 mg, usually following a titration schedule.

What are the primary goals of Retatrutide therapy?

The primary objectives are to enhance glucose regulation, promote significant weight reduction, and improve overall metabolic health in patients with obesity or T2DM.

How is Retatrutide administered during research?

In clinical trial settings, Retatrutide is administered via subcutaneous injection on a once-weekly basis.

Custom Retatrutide CAS 2381089-83-2: Innovative Obesity & T2DM Treatment from China Suppliers & Factory Manufacturers, Service

Product Description

Mechanism & Efficacy

Dosage & Research Use

Frequently Asked Questions

Related Products

High-Quality Cargrilintide CAS 1415456-99-3 - High-Quality Peptide from China Suppliers and Factory Manufacturers, Service

High-Quality Mots-C Peptide 16 Amino Acids - China Suppliers and Factory for Metabolic Regulation and Insulin Sensitivity Quotes, Service

High-Quality Bremelanotide/PT141 CAS 189691-06-3 - China Suppliers & Factory for Melanocortin Receptor Agonist Manufacturers, Pricelist

High-Quality Survodutide CAS 2805997-46-8 - Premium China Suppliers & Factory for High-Quality Peptides Manufacturer, Manufacturers

High-Quality Orforglipron CAS 2212020-52-3 - Top China Suppliers & Factory for High-Quality Pharmaceutical Ingredients Pricelist, Service

High-Quality Thymalin CAS 63958-90-7 - China Suppliers Factory for Immune System Support & Polypeptide Therapy Quotes, Service

High-Quality Dulaglutide CAS 923950-08-7 - Leading China Suppliers and Reliable Factory for High-Quality Production Manufacturers, Service

High-Quality Copper Tripeptide (GHK-Cu) CAS:89030-95-5 - Premium Quality from China Suppliers & Factory Quotes, Service

Custom Semax Peptide CAS 80714-61-0 - Top China Suppliers & Factory for Enhanced CNS Effects Pricelist, Service

Custom BPC-157 CAS:137525-51-0 - High-Quality Tissue Repair Peptide from China Suppliers and Factory Manufacturer, Pricelist